Literature DB >> 12352634

The clinical and morphologic spectrum of renal cryoglobulinemia.

Srinivasan Beddhu1, Sheldon Bastacky, John P Johnson.   

Abstract

We review the clinical and histologic features of 17 patients with cryoglobulinemia and renal disease. Most cases were associated with evidence of hepatitis C virus (HCV), although a significant minority had no evidence of HCV. The most common histologic pattern for renal involvement was membranoproliferative glomerulonephritis, which was seen in both HCV-positive and HVC-negative patients. Clinical presentation was variable, including nephrotic syndrome, unexplained elevations of serum creatinine, acute renal failure, or extrarenal manifestations. All patients had type II or type III cryoglobulins and all had low serum complements at presentation. Liver function abnormalities in HCV-positive patients were mild. No clinical or laboratory features beyond hepatitis serologies were helpful in distinguishing between HCV-positive and HCV-negative patients. All but 1 HCV-positive patient were treated with interferon (IFN) in either standard or high dosage, and this treatment was largely ineffective. Five of 11 HCV-positive patients progressed to renal failure. HCV patients treated with cyclophosphamide did not develop active liver disease. In all HCV-negative patients, renal function stabilized or improved, and 5 of 6 were treated with cyclophosphamide. In our series, there is limited experience with IFN-ribavirin therapy, which was not well tolerated. Renal cryoglobulinemia is an uncommon illness of diverse etiologies and clinical presentations. Morphologic presentation is also varied. IFN alone is often inadequate therapy for HCV-associated cryoglobulinemia. Experience with IFN-ribavirin in this entity is limited, but has shown promise in hepatic disease and has shown efficacy in HCV-associated cryoglobulinemia. Cyclophosphamide is the treatment of choice for HCV-negative patients and can be used safely in most HCV-positive patients if they fail IFN or IFN-ribavirin therapy, or if they require more aggressive therapy during periods of rapid clinical progression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12352634     DOI: 10.1097/00005792-200209000-00005

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  33 in total

1.  Spectrum and Prognosis of Noninfectious Renal Mixed Cryoglobulinemic GN.

Authors:  Mohamad Zaidan; Benjamin Terrier; Agnieszka Pozdzik; Thierry Frouget; Nathalie Rioux-Leclercq; Christian Combe; Sébastien Lepreux; Aurélie Hummel; Laure-Hélène Noël; Isabelle Marie; Bruno Legallicier; Arnaud François; Antoine Huart; David Launay; Gilles Kaplanski; Frank Bridoux; Philippe Vanhille; Raifah Makdassi; Jean-François Augusto; Philippe Rouvier; Alexandre Karras; Chantal Jouanneau; Marie-Christine Verpont; Patrice Callard; Fabrice Carrat; Olivier Hermine; Jean-Marc Léger; Xavier Mariette; Patricia Senet; David Saadoun; Pierre Ronco; Isabelle Brochériou; Patrice Cacoub; Emmanuelle Plaisier
Journal:  J Am Soc Nephrol       Date:  2015-08-10       Impact factor: 10.121

2.  A case of acute renal failure of multiple myeloma due to monoclonal type I cryoglobulinemia with thrombotic microangiopathy.

Authors:  Masaki Okazaki; Takaaki Yaomura; Toshiki Tsuboi; Shige Mizuno; Tomonobu Nakamura; Takakazu Hasegawa; Masao Katayama; Hiroyuki Nakamura; Hiroatsu Iida; Toshiki Saito; Shoichi Maruyama; Seiichi Matsuo
Journal:  CEN Case Rep       Date:  2014-12-30

Review 3.  Distinguishing diabetic nephropathy from other causes of glomerulosclerosis: an update.

Authors:  K O Alsaad; A M Herzenberg
Journal:  J Clin Pathol       Date:  2007-01       Impact factor: 3.411

Review 4.  [Renal manifestations of rheumatic diseases].

Authors:  A Schwarting; E Märker-Hermann
Journal:  Z Rheumatol       Date:  2005-02       Impact factor: 1.372

5.  Chronic hepatitis C virus infection: prevalence of extrahepatic manifestations and association with cryoglobulinemia in Bulgarian patients.

Authors:  Diana V Stefanova-Petrova; Anelia H Tzvetanska; Elisaveta J Naumova; Anastasia P Mihailova; Evgenii A Hadjiev; Rumiana P Dikova; Mircho I Vukov; Konstantin G Tchernev
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

Review 6.  Hepatotropic viral infection associated systemic vasculitides-hepatitis B virus associated polyarteritis nodosa and hepatitis C virus associated cryoglobulinemic vasculitis.

Authors:  Aman Sharma; Kusum Sharma
Journal:  J Clin Exp Hepatol       Date:  2013-07-08

Review 7.  Hepatitis C virus infection induced vasculitis.

Authors:  Patrice Cacoub; David Saadoun
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

8.  Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).

Authors:  Roberto Minutolo; Alessio Aghemo; Antonio Chirianni; Fabrizio Fabrizi; Loreto Gesualdo; Edoardo G Giannini; Paolo Maggi; Vincenzo Montinaro; Ernesto Paoletti; Marcello Persico; Francesco Perticone; Salvatore Petta; Massimo Puoti; Giovanni Raimondo; Maria Rendina; Anna Linda Zignego
Journal:  Infection       Date:  2018-09-25       Impact factor: 3.553

9.  Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).

Authors:  Roberto Minutolo; Alessio Aghemo; Antonio Chirianni; Fabrizio Fabrizi; Loreto Gesualdo; Edoardo G Giannini; Paolo Maggi; Vincenzo Montinaro; Ernesto Paoletti; Marcello Persico; Francesco Perticone; Salvatore Petta; Massimo Puoti; Giovanni Raimondo; Maria Rendina; Anna Linda Zignego
Journal:  J Nephrol       Date:  2018-09-25       Impact factor: 3.902

10.  Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).

Authors:  Roberto Minutolo; Alessio Aghemo; Antonio Chirianni; Fabrizio Fabrizi; Loreto Gesualdo; Edoardo G Giannini; Paolo Maggi; Vincenzo Montinaro; Ernesto Paoletti; Marcello Persico; Francesco Perticone; Salvatore Petta; Massimo Puoti; Giovanni Raimondo; Maria Rendina; Anna Linda Zignego
Journal:  Intern Emerg Med       Date:  2018-09-25       Impact factor: 3.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.